Beginning in 1968 A Lifetime of Research in Physics, Biology, Chemistry, Psychology,
Medicine & Law
The Camelot Foundation IRB was Reactivated for SARS-CoV-2 RCT.
by HHS on April 17, 2020. IRB00012532
2022 marks my 54th year of research in the fields of Physics and Medicine resulting in 185 published papers in peer-reviewed journals, 68 published abstracts at National and International Scientific Conferences, 9 Chapters in Medical Textbooks, 76 published eLetters to Scientific Journals, and Editor-in-Chief of 1 Cardiology Textbook. I have written 26 Medical books designed for both the General Public and Medical Professionals for a total of more than 450 publications.
My research has been included in 2 U.S. HHS Agency for Healthcare Research and Quality (AHRQ) reports, as well as 1 European Atherosclerosis Society Position Paper. I was a HHS Grant Reviewer from 2012-2016 and have reviewed for 32 Peer reviewed Medical and Physics Journals including 16 that I currently am either a Reviewer or Editor for.
I was asked to participate as a Moderator for the Obama-Biden Transition Team to discuss the Affordable Care Act (ACA) and did so in 2008. My research has been published in multiple newspapers, radio programs and podcasts and has been seen on such television programs as MSNBC, 20/20 and The Today Show.
I am the author of “The Fleming Inflammation and Heart Disease Theory” (Fleming Theory) first presented in 1994, inventor and patent holder of “The Fleming Method for Tissue and Vascular Differentiation and Metabolism Using Same State Single or Sequential Quantification Comparisons” (FMTVDM; FlemingMethod) issued in 2017, and the holder of 4 copyrights.
My work on SARS-CoV-2 and COVID-19 began in January of 2020 applying both the Fleming Theory and FlemingMethod. The first two research papers with their findings were published in November of 2020 with the third paper published in February of 2021. The fourth paper was accepted for publication in 2020 and pending final publication this year in the Chinese Medical Journal.